Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.
Pignata S, De Placido S, Biamonte R, Scambia G, Di Vagno G, Colucci G, Febbraro A, Marinaccio M, Lombardi AV, Manzione L, Cartenì G, Nardi M, Danese S, Valerio MR, de Matteis A, Massidda B, Gasparini G, Di Maio M, Pisano C, Perrone F. Pignata S, et al. Among authors: di vagno g, di maio m. BMC Cancer. 2006 Jan 7;6:5. doi: 10.1186/1471-2407-6-5. BMC Cancer. 2006. PMID: 16398939 Free PMC article. Clinical Trial.
Combined carboplatin plus ifosfamide and cisplatin in patients with advanced ovarian carcinoma. A phase I-II study. GOCS (Gynecological Oncology Cooperative Study).
Lorusso V, Leone B, Di Vagno G, Manzione L, Palmeri S, Vallejo C, Machiavelli M, Nacci G, Bilancia D, Leonardi V, Catino A, Gargano G, Loverro G, Selvaggi L, De Lena M. Lorusso V, et al. Among authors: di vagno g. Gynecol Oncol. 1998 Feb;68(2):172-7. doi: 10.1006/gyno.1997.4913. Gynecol Oncol. 1998. PMID: 9514802 Clinical Trial.
Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix.
Pignata S, Silvestro G, Ferrari E, Selvaggi L, Perrone F, Maffeo A, Frezza P, Di Vagno G, Casella G, Ricchi P, Cormio G, Gallo C, Iodice F, Romeo F, Fiorentino R, Fortuna G, Tramontana S. Pignata S, et al. Among authors: di vagno g. J Clin Oncol. 1999 Mar;17(3):756-60. doi: 10.1200/JCO.1999.17.3.756. J Clin Oncol. 1999. PMID: 10071263 Clinical Trial.
Hypersensitivity reactions in ovarian cancer patients receiving paclitaxel.
Cormio G, Di Vagno G, Melilli GA, Cazzolla A, Di Gesù G, Carriero C, Cramarossa D, Loverro G, Selvaggi L. Cormio G, et al. Among authors: di vagno g, di gesu g. J Chemother. 1999 Oct;11(5):407-9. doi: 10.1179/joc.1999.11.5.407. J Chemother. 1999. PMID: 10632389 Review.
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients.
Lorusso D, Ferrandina G, Greggi S, Gadducci A, Pignata S, Tateo S, Biamonte R, Manzione L, Di Vagno G, Ferrau' F, Scambia G; Multicenter Italian Trials in Ovarian Cancer invesitgators. Lorusso D, et al. Among authors: di vagno g. Ann Oncol. 2003 Jul;14(7):1086-93. doi: 10.1093/annonc/mdg301. Ann Oncol. 2003. PMID: 12853351 Free article. Clinical Trial.
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study.
De Placido S, Scambia G, Di Vagno G, Naglieri E, Lombardi AV, Biamonte R, Marinaccio M, Cartenì G, Manzione L, Febbraro A, De Matteis A, Gasparini G, Valerio MR, Danese S, Perrone F, Lauria R, De Laurentiis M, Greggi S, Gallo C, Pignata S. De Placido S, et al. Among authors: di vagno g. J Clin Oncol. 2004 Jul 1;22(13):2635-42. doi: 10.1200/JCO.2004.09.088. J Clin Oncol. 2004. PMID: 15226331 Clinical Trial.
Significance of erb-B2 immunoreactivity in cervical cancer.
Califano D, Losito S, Pisano C, Santelli G, Greggi S, Iodice F, DiVagno G, Silvestro G, Tambaro R, Formato R, Iaffaioli VR, Di Maio M, Pignata S. Califano D, et al. Front Biosci. 2006 Sep 1;11:2071-6. doi: 10.2741/1949. Front Biosci. 2006. PMID: 16720293
61 results